Upgrade to SI Premium - Free Trial

BriaCell Therapeutics (BCTX)

2.68 -0.20 (6.94%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/15/26 *Est.)

Latest Headlines

Form 10-Q BriaCell Therapeutics For: Apr 30 June 9, 2026 4:06 PM - SEC Filing Form 8-K BriaCell Therapeutics For: May 31 June 3, 2026 6:04 AM - SEC Filing Form 424B5 BriaCell Therapeutics June 2, 2026 8:01 AM - SEC Filing BriaCell Therapeutics Announces Pricing of Offering May 31, 2026 7:59 PM - Globe NewsWire BriaCell develops ovarian cancer immunotherapy candidate May 15, 2026 7:31 AM - StreetInsider BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™ May 15, 2026 7:30 AM - Globe NewsWire BriaCell completes manufacturing of prostate cancer therapy supplies May 14, 2026 7:31 AM - StreetInsider BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer May 14, 2026 7:30 AM - Globe NewsWire BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial May 13, 2026 7:30 AM - StreetInsider BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study May 13, 2026 7:30 AM - Globe NewsWire BriaCell enrolls over 230 patients in phase 3 breast cancer study May 12, 2026 7:30 AM - StreetInsider BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients May 12, 2026 7:30 AM - Globe NewsWire BriaCell adds NYU cancer center to phase 3 breast cancer trial May 7, 2026 7:30 AM - StreetInsider BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study May 7, 2026 7:30 AM - Globe NewsWire BriaCell receives FDA clearance for breast cancer immunotherapy trial May 6, 2026 7:31 AM - StreetInsider BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer May 6, 2026 7:30 AM - Globe NewsWire BriaCell Announces Six Clinical Data Presentations at ASCO 2026 April 27, 2026 7:30 AM - Globe NewsWire BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models April 21, 2026 7:30 AM - Globe NewsWire BriaCell presents cancer therapy data at 2026 AACR meeting April 20, 2026 7:31 AM - StreetInsider BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting April 20, 2026 7:30 AM - Globe NewsWire Form 8-K BriaCell Therapeutics For: Mar 31 March 31, 2026 4:11 PM - SEC Filing BriaCell subsidiary BriaPro completes sCD80 license acquisition March 31, 2026 4:06 PM - StreetInsider BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License March 31, 2026 4:05 PM - Globe NewsWire Full Article List